Related Experiment Videos
[Adenosine deaminase activity in Hodgkin's disease (author's transl)]
Insights
Adenosine deaminase (ADA) activity is lower in the lymphocytes of Hodgkin's disease patients compared to controls. This reduction in ADA enzyme activity may correlate with the immune system deficits observed in Hodgkin's disease.
Area of Science:
- Biochemistry
- Immunology
- Oncology
Context:
- Hodgkin's disease is a cancer of the lymphatic system.
- Cell-mediated immunity is crucial for immune response.
- Adenosine deaminase (ADA) is an enzyme involved in purine metabolism and immune function.
Purpose:
- To investigate adenosine deaminase (ADA) activity in patients with Hodgkin's disease.
- To compare ADA levels in blood plasma, erythrocytes, and lymphocytes between patients and controls.
- To explore the relationship between ADA activity and immune status in Hodgkin's disease.
Summary:
- Adenosine deaminase (ADA) activity was measured in blood plasma, erythrocytes, and lymphocytes of 23 Hodgkin's disease patients and 99 controls.
- Lymphocytes from Hodgkin's disease patients exhibited significantly lower ADA activity (U/g protein) compared to control subjects.
- No significant correlation was found between ADA activities in lymphocytes, erythrocytes, and plasma, and ADA levels were not reduced in plasma or erythrocytes.
Impact:
- Findings suggest that reduced lymphocyte ADA activity may be a biomarker for Hodgkin's disease.
- Lower ADA levels in lymphocytes could be linked to the impaired cell-mediated immunity characteristic of Hodgkin's disease.
- This research contributes to understanding the biochemical basis of immune dysfunction in Hodgkin's disease.
Abstract:
The activity of adenosine deaminase (ADA) (EC3.5.4.4.) was determined in the blood plasma, erythrocytes, and lymphocytes of 23 patients with Hodgkin's disease and partly also in 99 control subjects. The enzyme activities were measured using adenosine as substrate and by analysis of ammonia. No correlation was found between the ADA activities in lymphocytes, erythrocytes, and blood plasma. The lymphocytes of the patients revealed lower ADA activities (U/g protein) than the lymphocytes of control subjects. The ADA activity is not reduced in plasma or erythrocytes. The lower activities of ADA in the lymphocytes of patients may be related to the impaired cell-mediated immunity of the Hodgkin's disease.